Citation: Hu. Rehman et Sl. Atkin, Growth hormone-secreting pituitary macroadenoma and meningioma in a woman - A case report and review of the literature, ENDOCRINOLO, 11(4), 2001, pp. 335-337
Citation: Cj. Newton et al., Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitarytumour cells, J ENDOCR, 169(2), 2001, pp. 249-261
Authors:
Idiculla, JM
Beckett, G
Statham, PFX
Ironside, JW
Atkin, SL
Patrick, AW
Citation: Jm. Idiculla et al., Autoimmune hypothyroidism coexisting with a pituitary adenoma secreting thyroid-stimulating hormone, prolactin and alpha-subunit, ANN CLIN BI, 38, 2001, pp. 566-571
Citation: Cj. Newton et al., Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride, J STEROID B, 73(1-2), 2000, pp. 29-38
Authors:
Leong, KS
Foy, PM
Swift, AC
Atkin, SL
Hadden, DR
MacFarlane, IA
Citation: Ks. Leong et al., CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas, CLIN ENDOCR, 52(1), 2000, pp. 43-49
Citation: V. Speirs et al., Identification of wild-type and exon 5 deletion variants of estrogen receptor beta in normal human mammary gland, J CLIN END, 85(4), 2000, pp. 1601-1605
Authors:
Speirs, V
Kerin, MJ
Walton, DS
Newton, CJ
Desai, SB
Atkin, SL
Citation: V. Speirs et al., Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells, BR J CANC, 82(7), 2000, pp. 1312-1316
Authors:
Speirs, V
Kerin, MJ
Newton, CJ
Walton, DS
Green, AR
Desai, SB
Atkin, SL
Citation: V. Speirs et al., Evidence for transcriptional activation of ER alpha by IL-1B in breast cancer cells, INT J ONCOL, 15(6), 1999, pp. 1251-1254
Citation: Hu. Rehman et Sl. Atkin, Sleep disturbances and cardiac arrhythmia after treatment of a craniopharyngioma, J ROY S MED, 92(11), 1999, pp. 585-586
Authors:
Newton, CJ
Drummond, N
Burgoyne, CH
Speirs, V
Stalla, GK
Atkin, SL
Citation: Cj. Newton et al., Functional inactivation of the oestrogen receptor by the antioestrogen, ZM182780, sensitises tumour cells to reactive oxygen species, J ENDOCR, 161(2), 1999, pp. 199-210
Authors:
Green, VL
Speirs, V
Landolt, AM
Foy, PM
Atkin, SL
Citation: Vl. Green et al., 17 beta-hydroxysteroid dehydrogenase type 1, 2, 3, and 4 expression and enzyme activity in human anterior pituitary adenomas, J CLIN END, 84(4), 1999, pp. 1340-1345
Authors:
Speirs, V
Parkes, AT
Kerin, MJ
Walton, DS
Carleton, PJ
Fox, JN
Atkin, SL
Citation: V. Speirs et al., Coexpression of estrogen receptor alpha and beta: Poor prognostic factors in human breast cancer?, CANCER RES, 59(3), 1999, pp. 525-528
Authors:
Speirs, V
Malone, C
Walton, DS
Kerin, MJ
Atkin, SL
Citation: V. Speirs et al., Increased expression of estrogen receptor beta mRNA in tamoxifen-resistantbreast cancer patients, CANCER RES, 59(21), 1999, pp. 5421-5424
Citation: V. Speirs et al., In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6, BR J CANC, 81(4), 1999, pp. 690-695
Citation: V. Speirs et Sl. Atkin, Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours, BR J CANC, 80(5-6), 1999, pp. 898-903
Citation: V. Speirs et al., Activity and gene expression of 17 beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: The role of IL-8, J STEROID B, 67(3), 1998, pp. 267-274